0000905148-23-000783.txt : 20230823
0000905148-23-000783.hdr.sgml : 20230823
20230823161955
ACCESSION NUMBER: 0000905148-23-000783
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230821
FILED AS OF DATE: 20230823
DATE AS OF CHANGE: 20230823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blume-Jensen Peter
CENTRAL INDEX KEY: 0001950499
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41551
FILM NUMBER: 231197836
MAIL ADDRESS:
STREET 1: C/O ACRIVON THERAPEUTICS, INC.
STREET 2: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781174
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825125532
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-207-8979
MAIL ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
form4.xml
X0508
4
2023-08-21
0001781174
Acrivon Therapeutics, Inc.
ACRV
0001950499
Blume-Jensen Peter
C/O ACRIVON THERAPEUTICS, INC.
480 ARSENAL WAY, SUITE 100
WATERTOWN
MA
02472
true
true
President and CEO
false
Common Stock
2023-08-21
4
A
0
493994
0
A
2897696
D
Common Stock
320705
I
See footnote
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Of these RSUs, 1/3rd shall vest on the one-year anniversary of the grant date, and the remaining RSUs shall vest in eight equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.
These securities are held by co-founder and EVP, Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
2023-08-23